
≥99% (HPLC)
T1rz3pat1d3 20MG PEN
Dual GIP/GLP-1 Receptor Agonist
£84.99
A 20mg research preparation targeting GIP and GLP-1 receptor pathways involved in metabolic signalling.
Out of stock
1 pen · SKU TIRZ-20PEN
Frequently bought with
- T1rz3pat1d3
£79.99
- BPC-157
£27.99
**Tirzepatide 20mg Research Pen** A convenient pre-filled research pen containing **20mg of Tirzepatide**. Tirzepatide is a peptide that acts as a **dual GIP and GLP-1 receptor agonist**. These receptors are involved in metabolic signalling, glucose regulation, appetite and energy balance. Research involving tirzepatide has investigated its effects on glucose metabolism, insulin signalling, appetite regulation, energy intake and body-weight management. **Contents per pen:** • Tirzepatide — 20mg **Total — 20mg** The pre-filled pen format provides a convenient and straightforward preparation for research applications compared with individual research vials. **Important:** This product is supplied strictly for laboratory and research purposes only. Not for human consumption or therapeutic use.
Specification
≥99% (HPLC)
- Storage
- −20 °C, protect from light
Delivery and handling
Dispatched within one working day. Chosen at checkout: Royal Mail Tracked 24 at £4.99 or Tracked 48 at £3.99, and Tracked 24 free on orders over £99.99. Tracking arrives by email as soon as the label is printed.
Storage and handling
Store the pen at −20 °C, protect from light, in its original packaging.
Returns
Consumers have 14 days from delivery to cancel under the Consumer Contracts Regulations 2013. Once a seal is broken the pen cannot be resold, so opened items are non-returnable. That does not affect your statutory rights. Under the Consumer Rights Act 2015 you have 30 days to reject anything faulty, wrongly supplied or not as described, opened or not, and we refund it in full and cover the return.
All products are sold for laboratory research purposes only. They are not medicines, not dietary supplements, and are not for human or veterinary consumption.
Cross-reference






